Inhibikase Therapeutics, Inc.
IKT
$2.41
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 81.39% | 82.84% | 83.27% | 2,283.84% | 1,004.10% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 38.21% | 39.78% | -61.48% | 132.04% | 98.37% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 412.75% | 596.65% | 1,163.22% | -10.12% | 42.23% |
| Total Current Assets | 82.83% | 82.85% | 82.94% | 1,774.34% | 932.16% |
|
|
|||||
| Total Current Assets | 82.83% | 82.85% | 82.94% | 1,774.34% | 932.16% |
| Net Property, Plant & Equipment | -- | -- | -- | -100.00% | -73.84% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 84.11% | 83.85% | 83.78% | 1,718.51% | 906.63% |
|
|
|||||
| Total Accounts Payable | -63.32% | -6.19% | 22.81% | -75.47% | 101.69% |
| Total Accrued Expenses | 194.62% | 17.41% | 52.29% | 69.17% | 54.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -75.10% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 16.60% | -33.20% | 122.33% | 36.45% | 137.54% |
|
|
|||||
| Total Current Liabilities | 16.60% | -33.20% | 122.33% | 36.45% | 137.54% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 16.60% | -33.20% | 122.33% | 36.45% | 135.91% |
|
|
|||||
| Common Stock & APIC | 67.64% | 68.55% | 66.68% | 148.11% | 142.71% |
| Retained Earnings | -51.38% | -47.14% | -51.11% | -57.92% | -54.25% |
| Treasury Stock & Other | -2,410.34% | -2,530.00% | 158.60% | -333.33% | -190.00% |
| Total Common Equity | 91.53% | 95.52% | 82.26% | 13,838.84% | 1,470.73% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 91.53% | 95.52% | 82.26% | 13,838.84% | 1,470.73% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 91.53% | 95.52% | 82.26% | 13,838.84% | 1,470.73% |
|
|
|||||